
Use of18F-fludeoxyglucose positron emission tomography-CT in the management of breast implant-associated anaplastic large cell lymphoma
Author(s) -
Sapna Ladani,
Kalliope Valassiadou,
Yvette Griffin,
Fiona Miall
Publication year - 2016
Publication title -
bjr case reports
Language(s) - English
Resource type - Journals
ISSN - 2055-7159
DOI - 10.1259/bjrcr.20150424
Subject(s) - anaplastic large cell lymphoma , breast implant , positron emission tomography , medicine , lymphoma , capsule , lesion , positron emission , implant , radiology , effusion , tomography , nuclear medicine , pathology , surgery , biology , botany
The prognosis and preferred management of breast implant-associated anaplastic large cell lymphoma is dependent on whether lymphoproliferative cells are confined to within the fibrous capsule, in an effusion or lining the fibrous capsule, or if there is spread beyond the capsule in the form of a mass lesion. We describe a case where 18 F-fludeoxyglucose positron emission tomography-CT was used to confirm localized disease and guide management decisions.